Diagnostic Cardiology at Baxter - U.S.
Mark Querry has extensive work experience in the financial and medical device industries. Mark served as the CFO at Bardy Diagnostics, where they introduced the world's first P-wave centric cardiac monitoring device. Prior to that, they were the President of Electronics Management, where they transformed a struggling electronics recycling business into a successful refurbishment and re-marketing company. Mark also worked as a Principal at Alcyone Partners, providing financial and operational advice to medical device companies. Additionally, they served as the CFO at Calypso Medical Technologies, leading the company from its start-up phase to its eventual sale. Mark started their career as a Director of Finance & Administration at EKOS Corporation and a Finance Manager at Abbott Laboratories. Mark is skilled in financial modeling, healthcare reimbursement, and international auditing.
Mark Querry attended Hillsdale College from 1983 to 1987, where they obtained a Bachelor of Arts degree in English Literature/Accounting with Magna Cum Laude distinction. In addition, they hold a non-active Certified Public Accountant (CPA) certification from the State of Illinois, although the specific month and year of obtaining this certification are not provided.
Diagnostic Cardiology at Baxter - U.S.
1 followers
Bardy Diagnostics is a developer of a cardiac monitor and arrhythmia detection device. The company has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Itsunique, narrow, hourglass shape makes it especially advantageous for the female anatomy. It is also designed to be comfortable for women to wear, with its narrow, hourglass shape.Bardy Diagnostics uses his expertise to develop cardiac monitoring solutions that help physicians obtain more accurate information about actionable events in the hopes of saving lives. The company's mission is to improve clinical management and outcomes for patients and their physicians by employing innovative P-wave centric ECG detection into patient-friendly technologies that result in greater patient compliance and more confident physician diagnoses.Bardy Diagnostics was founded in 2013 and is headquartered in Seattle, Washington, USA.